Nadir bir ileus nedeni olarak sklerodermanın intestinal tutulumu: Olgu sunumu

Süleyman Demirel Üniversitesi TIP FAKÜLTESİ DERGİSİ: 2007 Eylül; 14(3) Nadir bir ileus nedeni olarak sklerodermanın intestinal tutulumu: Olgu sunumu Mesut Dede, Ibrahim Barut, Ömer Rıdvan Tarhan Süleyman Demirel Üniversitesi Tıp Fakültesi Genel Cerrahi Anabilim Dalı, Isparta, Özet Skleroderma kollogen depozitlerinin birikimiyle beraber, fibrozis ve mikrovasküler hasar oluşturan sistemik bir hastalıktır. Deriden sonra en sık gastrointestinal sistem tutulur. Sklerodermadaki primer patolojik değişiklik düz kasların fibrozis ile yer değiştirmesidir. Bu da pseudoobstrüksiyonun primer nedenidir. Karın ağrısı, bulantı, kusma, abdominal şişkinlik, konstipasyon, fekal inkontinans sık görülen semptomlardır. Bu makalede sklerodermanın intestinal tutulumu olan olgumuz sunulmaktadır. Anahtar kelimeler: Skleroderma, intestinal tutulum, ileus Abstract Scleroderma; As a Rare Cause of Intestinal Obstruction: Report of a Case Scleroderma is a systemic disease causing microvasculary injury and fibrosis accompanying with collagen deposits. Gastrointestinal system is the second most frequent involvement site after skin. Fibrotic changes of smooth muscles are the primary histopathological change in scleroderma. This is the primary cause of pseudo-obstruction. Abdominal pain, distention, nausea, vomiting, constipation, and fecal incontinence are frequent symptoms. Here we report a case of scleroderma with intestinal involvement. Key words: Scleroderma, intestinal involvement, intestinal pseudo obstruction.

Anahtar Kelimeler:

Skleroderma, intestinal tutulum, ileus

PDF

___

Kobayashi T, Kobayashi M, Naka M, Nakijima K,
Momose A, Toi M.:Response to octreotide of intestinal pseudoobstruction and pneumatosis cystoides intestinalis associated with progressive systemic sclerosis.Gastroenterology. 1988;95(4):1114-8
Rohrmann CA Jr, Ricci MT, Krishnamurthy S, Schuffler MD.:Radiologic and histologic differentiation of neuromuscular disorders of the gastrointestinal tract:Visceral myopathies and progressive systemic sclerosis. Gastroenterelogy.1979;77(4 Pt 1):664-71
Schuffler MD, Beegle RG: Progressive systemic sclerosis of the gastrointestinal tract and hereditary hollow visceral myopathy: Two distinguishable disorders of intestinal muscle. Eur Emerg Med. 2001;8(4):333-5
Ortiz-Alvarez O: Intestinal pseudo-obstuction as an initial presentation of systemic sclerosis in two children. Dig Dis Sci. 1995;40(9): 1892-901
Michele A. Young, MD, Suzanne Rose, MD AND James C.Reynolds, MD: Gastrointestinal manifestations of scleroderma. Rheumatic Disease Clinics of North America 1996;22(4):797-813-817
Stafford-Brady FJ, Kahn HJ, Ross TM, Russell ML.:Advenced scleroderma bowel:Complications and management. AJR Am Roentgenol 1984;143(5):933- 41
A.V. Emmanuel, A.G. Shand and M.A. Kamm: Erythromycin for the treatment of chronic intestinal pseudo-obstruction: Description of six cases with a positive response. Aliment Pharmacol Ther 2004;19:687-693
Venizelos ID, Shousha S, Bull TB , Parkins RA.: Chronic intestinal pseudo-obtruction in two patients. Overlap of features of systemic sclerosis and visceral myopathy. J Rheumatol. 1988;15(5):869-74.
Exadaktylos A, Papagrigoriadis S.: Chronic constipation-a lethal danger in patients with systemic scleroderma. Br J Rheumatol. 1997;36(2):280-4
Verne GN, Eaker EY, Hardy E, Sninsky CA.: Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction. Ýntern Med. 1993;32(7):607-9